Exemption from excise duty on Rifampicin and its formulations confirms non-requirement to pay previously unlevied duty. The Central Government directs that the whole of the excise duty otherwise payable on Rifampicin and formulations of Rifampicin with Isoniazid (INH) shall not be required to be paid in respect of such goods on which duty was not levied during 18 January 1989 to 15 May 1989 in accordance with an established practice of non-levy. The notification defines covered products as medicaments containing the bulk drugs Rifampicin and Isoniazid with therapeutically inert pharmaceutical aids, and notes that the term bulk drug has the meaning assigned in the relevant drug price control order.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Exemption from excise duty on Rifampicin and its formulations confirms non-requirement to pay previously unlevied duty.
The Central Government directs that the whole of the excise duty otherwise payable on Rifampicin and formulations of Rifampicin with Isoniazid (INH) shall not be required to be paid in respect of such goods on which duty was not levied during 18 January 1989 to 15 May 1989 in accordance with an established practice of non-levy. The notification defines covered products as medicaments containing the bulk drugs Rifampicin and Isoniazid with therapeutically inert pharmaceutical aids, and notes that the term bulk drug has the meaning assigned in the relevant drug price control order.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.